In previous studies, GLI1 signal transduction and other pathways, including the NF-κB signaling pathway, were usually studied in tumor-associated diseases and are considered a response network that promotes cancer development (Wils and Bijlsma, 2018; Zeng and Ju, 2018). This evidence concerns the gene NFKB1 and cancer.